Search Results

Press Releases

Standard BioTools Completes Sale of SomaLogic to Illumina

February 1, 2026

·

6 min read

Press Releases

Standard BioTools Enters Next Phase of Transformation with Strategic Sale of SomaLogic to Illumina

June 23, 2025

·

9 min read

Deals

Dr. Larry Gold and Dr. Jason Cleveland Issue Open Letter to SomaLogic Stockholders Opposing SomaLogic’s Proposed Merger with Standard BioTools

Dr. Larry Gold, the founder of SomaLogic, Inc. and Dr. Jason Cleveland, SomaLogic’s current Chief Technology Officer, are issuing the below letter to SomaLogic’s stockholders regarding their opposition to the Company’s proposed merger with Standard BioTools, Inc. .

December 28, 2023

·

5 min read

Deals

SomaLogic Stockholders Vote to Approve Standard BioTools Transaction at Special Meeting

SomaLogic, Inc., a leader in proteomics technology, announced that, based on the preliminary vote count provided by its proxy solicitors following the Company’s Special Meeting of Stockholders held earlier today, SomaLogic stockholders voted to approve the transaction with Standard BioTools Inc. .

January 4, 2024

·

7 min read

BioMidwest

SomaLogic Board Reiterates Value-Maximizing Transaction with Standard BioTools is in Best Interests of All Stockholders

SomaLogic, Inc., a leader in proteomics technology, sent the following open letter to stockholders reiterating the Board’s belief that the proposed transaction between SomaLogic and Standard BioTools is in the best interest of all stockholders.

December 29, 2023

·

17 min read

Deals

Standard BioTools Stockholders Approve Merger with SomaLogic

Standard BioTools Inc., driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health, announced that its stockholders voted to approve all proposals required to be approved in connection with the pending merger with SomaLogic at its Special Meeting of Stockholders.

January 4, 2024

·

7 min read

BioMidwest

SomaLogic expands agreement with Novo Nordisk to 2025

SomaLogic, Inc., a leader in proteomics technology, announced that it is extending its collaborative agreement with global healthcare innovator, Novo Nordisk.

September 5, 2023

·

4 min read

Deals

SomaLogic Issues Letter to Stockholders Reiterating Recommendation for Value Maximizing Merger with Standard BioTools

SomaLogic, Inc. issued an open letter to stockholders highlighting the value maximizing merger entered into with Standard BioTools on October 4, 2023.

December 21, 2023

·

16 min read

Deals

SomaLogic Issues Statement Correcting Madryn Asset Management’s Misleading Disclosure

SomaLogic, Inc., a leader in proteomics technology, issued the following statement in response to a press release issued by Madryn Asset Management, LP on December 26, 2023, regarding the pending merger with Standard BioTools.

December 26, 2023

·

17 min read

BioMidwest

SomaLogic Urges Stockholders to Maximize Value of Their Investment by Voting “FOR” Pending Merger with Standard BioTools

SomaLogic, Inc., a leader in proteomics technology, sent the following open letter to stockholders urging them to vote “FOR” the value maximizing transaction with Standard BioTools.

January 2, 2024

·

15 min read